Skip to content

Honey effect on cough alleviation

Comparison Study of Honey versus Diphenhydramine Effect on Cough Alleviation in 2-5 Years Old Children with Viral Upper Respiratory Tract Infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110247882N1
Enrollment
126
Registered
2012-11-27
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Cold. Acute nasopharyngitis

Interventions

Intervention 1: Diphenhydramin syrup, 5mg/kg/TDS,for 48 h. Intervention 2: Honey with the same volume and frequency and duration of use with diphenhydramine.
Treatment - Drugs
Diphenhydramin syrup, 5mg/kg/TDS,for 48 h
Honey with the same volume and frequency and duration of use with diphenhydramine

Sponsors

Hormozgan University of Medical Sciences(HUMS)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 5 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:The patients's age is two to five years old; Acute cough is the chief complaint;The symptoms of viral upper respiratory tract infection are the only concomitant symptoms [fever (oral temperature from 37.8to 38.5 or axillary temp from 37.2 to 37.9) rhinorrhea , sneezing, blocked nose, sore throat, cough, mild headache, restlessness, hoarseness];The patient has been brought to clinic at first or second day of begining cough;The patient has not bacterial infections symptoms of upper respiratory tract (moderate to high fever, sever sore throat with painful swallowing, severe headache, nausea, vomiting, abdominal pain, ...);The patient has not the symptoms of lower respiratory tract infection (high fever, chills, dyspnea, malaise, pleuritic chest pain, tachypnea, retraction); There are not associated infections such as otitis and sinusitis; Allergy is not considered ( associated symptoms such as itchy eye & nose, history of repeating similar symptoms, a history of prolonged cold periods, positive family history; The patient has not signs of Reactive Airway Disease (wheezing, shortness of breath,pressure or tightness feeling in chest , tachypnea, tachycardia); The parents have not begun any drug before coming to clinic . Exclusion criteria were: Onset of otitis or sinusitis symptoms; Onset of symptoms of lower respiratory tract involvement; Adding a bacterial infection, (purulent nasal discharge, high fever, difficulty breathing, Periorbital edema, facial pain); Not using of recommended treatments; Adding other drugs to recommended treatment; Non-coordinated reports of persons who take care of patients.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Number of Night cough. Timepoint: Before intervention, 48 h after intervention. Method of measurement: Visual scale of the number of coughs.;Severity of night cough. Timepoint: Before intervention, 48 h after intervention. Method of measurement: Visual scale of severity of coughs.;The number of daily cough. Timepoint: Before intervention, 48 h after intervention. Method of measurement: Visual scale of the number of coughs.;Severity of daily cough. Timepoint: Before intervention, 48 h after intervention. Method of measurement: Visual scale of severity of cough.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahshid Ahmadi

Mazandaran University of Medical Sciences

mshahmadi@yahoo.com+98 15 1320 7026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026